GEROTHERAPEUTIX Trademark

Trademark Overview


On Thursday, February 27, 2025, a trademark application was filed for GEROTHERAPEUTIX with the United States Patent and Trademark Office. The USPTO has given the GEROTHERAPEUTIX trademark a serial number of 99059580. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, September 25, 2025. This trademark is owned by SENOTHERAPEUTIX, Inc.. The GEROTHERAPEUTIX trademark is filed in the Pharmaceutical Products, Personal and Legal & Social Services categories with the following description:

Anti-aging therapy;Anti-aging services;Anti-aging research;Pharmaceutical products for the prevention and treatment of cancer and other age-related skin disorders;Gene therapy-based pharmaceutical products for the prevention and treatment of cancer and other age-related skin disorders;Development of pharmaceutical preparations and medicines;Research and development of pharmaceuticals for the treatment of age-related diseases and cancer;Testing, inspection, research, or development of pharmaceutical preparations for age therapy and gene therapy;Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics;Peptides for use in age-related diseases and cancer;Peptides for use in skin conditions;Anti-aging peptides;Peptides for use in prevention of radiation damage;Peptides for use in treatment of radiation damage;Peptides for use in prevention of radiation related diseases;Peptides for use in treatment of ...

Medical advisory services;Medical advisory services, namely, anti-aging services;Medical advisory services, namely, prevention and treatment of age-related disorders;Medical testing services;Medical testing services, namely, anti-aging services;Medical testing services, namely, prevention and treatment of age-related disorders;Medical services in the field of anti-aging;Medical services in the field of senescent cells;Medical services in the field of age-related disorders;Biopsy services;Biopsy services related to biologic age;Biopsy services related to biological age scoring;Biopsy services related to determining a number or percentage of senescent cells;Laboratory services;Laboratory services related to biologic age;Laboratory services related to biological age scoring;Laboratory services related to determining a number or percentage of senescent cells;Non-invasive testing;Non-invasive testing related to biologic age;Non-invasive testing related to biological age scoring;Non-invasive...
gerotherapeutix

General Information


Serial Number99059580
Word MarkGEROTHERAPEUTIX
Filing DateThursday, February 27, 2025
Status641 - NON-FINAL ACTION - MAILED
Status DateThursday, September 25, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesAnti-aging therapy;Anti-aging services;Anti-aging research;Pharmaceutical products for the prevention and treatment of cancer and other age-related skin disorders;Gene therapy-based pharmaceutical products for the prevention and treatment of cancer and other age-related skin disorders;Development of pharmaceutical preparations and medicines;Research and development of pharmaceuticals for the treatment of age-related diseases and cancer;Testing, inspection, research, or development of pharmaceutical preparations for age therapy and gene therapy;Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics;Peptides for use in age-related diseases and cancer;Peptides for use in skin conditions;Anti-aging peptides;Peptides for use in prevention of radiation damage;Peptides for use in treatment of radiation damage;Peptides for use in prevention of radiation related diseases;Peptides for use in treatment of radiation related diseases;Peptides for use in treatment of obesity;Peptides for use in weight loss regimens, Peptides for use in treatment of obesity in combination with other drugs;Gene therapy research;Gene therapy research related to anti-aging;Gene therapy research related to cancer;Gene therapy related to prevention and treatment of radiation damage and radiation related diseases;Gene therapy related to treatment of obesity;Gene therapy related to weight loss regimens;Gene therapy related to treatment of obesity in combination with other drugs;Biologic age scoring;Statistical scoring to determine a biologic age score of a patient;Medical services;Medical services, namely, anti-aging services;Medical services, namely, prevention and treatment of age-related disorders;Medical research services;Medical research services, namely, anti-aging services;Medical research services, namely, prevention and treatment of age-related disorders
Goods and ServicesMedical advisory services;Medical advisory services, namely, anti-aging services;Medical advisory services, namely, prevention and treatment of age-related disorders;Medical testing services;Medical testing services, namely, anti-aging services;Medical testing services, namely, prevention and treatment of age-related disorders;Medical services in the field of anti-aging;Medical services in the field of senescent cells;Medical services in the field of age-related disorders;Biopsy services;Biopsy services related to biologic age;Biopsy services related to biological age scoring;Biopsy services related to determining a number or percentage of senescent cells;Laboratory services;Laboratory services related to biologic age;Laboratory services related to biological age scoring;Laboratory services related to determining a number or percentage of senescent cells;Non-invasive testing;Non-invasive testing related to biologic age;Non-invasive testing related to biological age scoring;Non-invasive testing related to determining a number or percentage of senescent cells;Prevention of radiation damage;Treatment of radiation damage;Prevention of radiation related diseases;Treatment of radiation related diseases;Treatment of obesity;Weight loss regimens;Treatment of obesity in combination with other drugs;Anti-aging cream;Anti-aging serum;Cosmetic anti-aging products;Cosmetic preparations;Cosmetic research;Cosmetic creams for skin care;Cosmetic preparations for skin care;Peptides for use in cosmetics;Anti-aging peptides for use in cosmetics;Development of cosmetic preparations;Research and development of cosmetic preparations;Consulting services in the fields of anti-aging and cosmetics;Biologic age scoring for use in cosmetics;Statistical scoring to determine a biologic age score of an individual
Description of MarkThe mark consists of the word GEROTHERAPEUTIX in stylized black font where the X is formed by a partial lemniscate in blue.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 27, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, February 27, 2025
Primary Code045
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSENOTHERAPEUTIX, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSurfside, FL 33154

Trademark Events


Event DateEvent Description
Thursday, February 27, 2025NEW APPLICATION ENTERED
Thursday, February 27, 2025APPLICATION FILING RECEIPT MAILED
Tuesday, September 9, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 9, 2025NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, September 10, 2025ASSIGNED TO EXAMINER
Thursday, September 25, 2025NON-FINAL ACTION WRITTEN
Thursday, September 25, 2025NON-FINAL ACTION E-MAILED
Thursday, September 25, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 15, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, December 15, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED